Close

Pharmacyclics (PCYC) Tops Q3 EPS by 32c

November 4, 2014 4:39 PM EST

Pharmacyclics (NASDAQ: PCYC) reported Q3 EPS of $0.69, $0.32 better than the analyst estimate of $0.37. Revenue for the quarter came in at $307 million versus the consensus estimate of $201.5 million.

For earnings history and earnings-related data on Pharmacyclics (PCYC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings